Trending Market News
Oil prices rose more than 2% on Monday after Israel ordered troops to move deeper into Lebanon to battle Hezbollah, despite a ceasefire announced over six weeks ago. The increase reversed Friday's decline when markets had anticipated a U.S.-Iran ceasefire agreement.
- U.S. crude futures climbed 2.71% to $89.73 per barrel, while Brent futures rose 2.27% to $93.19 per barrel as of 1017 GMT
- The escalation in Lebanon involves Israeli forces engaging Iranian-backed Hezbollah militants in violation of a previously announced ceasefire
- Both Brent and WTI had fallen approximately 1.8% and 1.7% respectively on Friday on expectations of a U.S.-Iran ceasefire deal
Berkshire Hathaway announced it will acquire homebuilder Taylor Morrison Home Corporation for $8.5 billion in enterprise value. The deal values Taylor Morrison at $72.50 per common share. This acquisition expands Berkshire's presence in the residential construction sector.
- The acquisition price is set at $72.50 per common share of Taylor Morrison
- The transaction represents an $8.5 billion enterprise value for the homebuilder
- The deal was jointly announced by both companies on Sunday, May 31
Former Barclays CEO Jes Staley has agreed to be interviewed on July 23 by the House Oversight and Government Reform Committee about his relationship with sex offender Jeffrey Epstein. Staley resigned from Barclays in 2021 after a UK regulator investigated how he characterized his Epstein ties, and was later fined over $2 million and banned from UK financial management roles. The interview is part of a broader congressional inquiry that has included other high-profile figures connected to Epstein.
- Staley was a friend of Epstein during his time as a JPMorgan executive, where Epstein was a major client of the private wealth divisions Staley managed
- JPMorgan paid $290 million to Epstein victims in 2023 and $75 million to the U.S. Virgin Islands to settle lawsuits alleging the bank facilitated Epstein's crimes
- The Oversight Committee has already interviewed Bill Clinton, Hillary Clinton, Commerce Secretary Howard Lutnick, and former AG Pam Bondi, with additional interviews scheduled for Bill Gates (June 10) and others
Revolution Medicine's experimental pancreatic cancer drug daraxonrasib doubled survival time to 13.2 months versus 6.7 months with chemotherapy in a 500-person trial of patients who had failed initial treatment. The once-daily pill reduced the risk of death by 60% and improved quality of life enough that some patients resumed abandoned activities. The drug targets RAS mutations present in up to 90% of pancreatic cancers and has received FDA priority review.
- Daraxonrasib halted or reversed tumor progression in nearly 33% of patients versus 10% with chemotherapy, with tumors shrinking or disappearing in 31.6% versus 11.2% respectively
- While 86.3% of patients experienced rash, side effects were largely manageable with only 1.2% discontinuing treatment due to adverse events compared to 11.2% on chemotherapy
- The drug represents the first in a new class called RAS(ON) inhibitors and is already being tested in earlier-stage disease and combination therapies to extend survival benefits
Johnson & Johnson's prostate cancer drug Erleada, combined with hormone therapy before and after surgery, significantly improved outcomes in a late-stage trial of over 2,000 high-risk patients. The treatment made patients nine times more likely to have little to no detectable cancer at surgery and reduced disease progression or death risk by 20%. J&J plans to seek expanded regulatory approvals for this 'paradigm changing' approach to treating the roughly 40% of U.S. prostate cancer patients classified as high-risk.
- 8.9% of patients on the Erleada combination had little to no cancer at surgery versus only 1% on hormone therapy alone, with the treatment reducing recurrence or death risk by 20%
- Extended treatment (one full year) nearly doubled the time before patients needed additional therapy to over six years and reduced recurrence/death risk by 29%
- The drug would be the first androgen receptor pathway inhibitor approved for localized high-risk prostate cancer, addressing a major unmet need as nearly half of patients currently see cancer return after standard surgery and radiation
President Trump signed an executive order to accelerate research into psychedelic therapies for mental health conditions like PTSD and depression, marking a reversal from his first administration's stricter stance on controlled substances. The FDA issued priority review vouchers to three companies developing psychedelic treatments, sending investor interest surging. However, safety concerns and questions about whether political momentum is outpacing scientific rigor remain significant issues.
- MDMA-assisted therapy showed 71% of severe PTSD patients no longer met diagnostic criteria in clinical trials, though the FDA rejected approval in 2024 citing study design concerns and need for additional data
- The executive order specifically mentions ibogaine, which has not undergone large-scale U.S. trials and carries serious cardiovascular risks, raising researcher concerns about standards being relaxed for political reasons
- Critics suggest the timing may be politically motivated to regain veteran support ahead of midterm elections, particularly as the administration pursues VA staffing cuts
An experimental lung cancer drug called ivonescimab, developed by Akeso and Summit Therapeutics, reduced death risk by 34% in a Phase 3 trial conducted in China, extending median survival by four months compared to standard treatment. The bispecific antibody targets both PD-1 (like Merck's Keytruda) and VEGF (like Roche's Avastin), representing a potentially significant advancement for hard-to-treat squamous non-small-cell lung cancer patients.
- Patients receiving ivonescimab plus chemotherapy lived a median of 27.9 months versus 23.7 months for those on standard PD-1 immunotherapy plus chemotherapy, a four-month survival improvement
- Bleeding complications occurred in nearly 25% of ivonescimab patients (twice the control group rate), raising safety concerns particularly for squamous lung cancer patients whose tumors are near major blood vessels
- Questions remain about whether results from the China-only trial will translate to Western populations, with a global Phase 3 study (Harmoni-3) expected to report results in the second half of this year
SoftBank Group announced plans to invest up to €75 billion (approximately $87 billion) to expand data center capacity in France, targeting up to 5 gigawatts of additional capacity. This represents SoftBank's largest AI infrastructure investment in Europe and aligns with France's ambition to become a leading destination in the AI value chain.
- The first phase will build data centers in Dunkirk, Bosquel, and Bouchain to deliver 3.1 gigawatts of capacity to the Hauts-de-France region by 2031
- French economic minister Roland Lescure cited the investment as supporting President Macron's goal to position France as a leader across the AI value chain
- SoftBank has also announced data center plans in the United States, including a facility in Ohio, despite ongoing environmental and electrical grid concerns in that market
Yum Brands is in exclusive negotiations to sell its Pizza Hut chain to private equity firm LongRange Capital, according to Bloomberg News. LongRange recently won exclusivity over competing bidders including Sycamore Partners. While discussions are advancing and a deal could materialize within weeks, no agreement is guaranteed.
- Private equity firm LongRange Capital entered exclusivity with Yum Brands in recent days, outbidding rivals including Sycamore Partners
- The potential transaction could be finalized in several weeks, though there is no guarantee negotiations will result in a completed deal
- Neither Yum Brands, LongRange Capital, nor Sycamore Partners provided immediate comment on the reported negotiations
U.S. investment firm Castlelake is in early stages of considering a potential acquisition bid for British budget airline Easyjet. No formal approach has been made to Easyjet's board, and there is no certainty a deal will materialize. Under UK takeover rules, Castlelake must submit a firm offer by June 26 or withdraw.
- Castlelake has not yet approached Easyjet's board and no offer terms have been determined
- UK takeover regulations require Castlelake to make a firm offer or walk away by June 26
- The potential deal involves a major U.S. investment firm targeting one of Britain's leading budget carriers
Universal Music Group's board rejected a takeover proposal from Bill Ackman's Pershing Square on May 29, stating the offer fundamentally undervalues the company. Pershing Square had proposed acquiring Universal Music through a vehicle valuing the company at approximately €30.40 per share in April. Universal, which represents major artists including Taylor Swift and Billie Eilish, plans to move its listing from Amsterdam to New York to attract broader investor participation and achieve higher valuations.
- Pershing Square's April proposal valued Universal Music at around €30.40 per share, which the board deemed materially inadequate
- Universal Music represents major global artists including Taylor Swift, Billie Eilish, and Kendrick Lamar
- The company plans to relocate its stock listing from Amsterdam to New York to enable index fund ownership and improve earnings and valuation prospects
U.S. crude oil production held steady at 13.7 million barrels per day in March 2026, according to the EIA, though output in Texas fell to a four-month low of 5.78 million bpd. Production is expected to increase in subsequent months as operators respond to elevated oil prices around $88 per barrel driven by conflict with Iran that began in late February.
- Texas crude production dropped to 5.78 million bpd (four-month low) while New Mexico held steady at 2.31 million bpd; together the states' Permian Basin accounts for roughly half of U.S. crude output
- U.S. natural gas production rose to 135.52 billion cubic feet per day in March, up from 134.63 bcfd in February, with Texas setting a new record at 38.68 bcfd
- U.S. crude and product demand fell to 20.38 million bpd, the lowest since November, though demand was still up 2.2% year-over-year
Democratic Senator Ed Markey requested information from TikTok's U.S. joint venture and Oracle regarding data security and safeguards against foreign manipulation of TikTok's content algorithm. This follows ByteDance's January deal to establish a majority American-owned joint venture to protect data from over 200 million U.S. users and avoid a platform ban. Oracle, a managing investor in the venture, will host the retrained algorithm in its U.S. cloud infrastructure.
- ByteDance finalized a deal in January 2026 to create a majority U.S.-owned joint venture (TikTok USDS JV) to secure American user data and prevent a U.S. ban
- Oracle serves as one of three managing investors and will host TikTok's content recommendation algorithm in its U.S. cloud after retraining on U.S. user data
- Senator Markey is seeking answers on data security measures and protections against foreign manipulation of the platform used by over 200 million Americans
Massachusetts Attorney General Andrea Joy Campbell filed a lawsuit on Friday against UnitedHealth Insurance, alleging the company defrauded the state's Medicaid program (MassHealth) out of at least $100 million. The suit claims UnitedHealthcare Community Plans of Massachusetts falsely manipulated health status data of members in its Senior Care Options plan to obtain higher payments from the state.
- The alleged fraud involves at least $100 million in improper payments from Massachusetts' Medicaid program
- UnitedHealth is accused of falsely manipulating the health status of MassHealth members enrolled in its Senior Care Options plan
- The lawsuit targets UnitedHealth Insurance, which operates as UnitedHealthcare Community Plans of Massachusetts
The Trump administration's Department of Homeland Security has threatened to halt international traveler and cargo processing at Newark and over a dozen other major U.S. airports in 'sanctuary cities' due to a dispute over local cooperation with federal immigration enforcement. Major airlines and business groups warn this could cause massive disruption, stranding thousands of travelers, disrupting supply chains, and damaging America's reputation just weeks before the U.S. co-hosts the FIFA World Cup.
- Over 20,000 international passengers land at Newark daily (including 14,000 U.S. citizens), and shutting down all 18 affected airports would impact 68 million international passengers annually and cost the economy over $70 billion
- The threatened action comes weeks before the FIFA World Cup final on July 19 in New Jersey, about 12 miles from Newark airport, raising concerns about damage to America's reputation as international visitors stream in
- Business groups warn that halting customs operations would disrupt critical cargo shipments including pharmaceuticals and semiconductor chips, with ripple effects across interconnected aviation networks nationwide
Ultium Cells, a battery plant joint venture between GM and LG Energy Solution in Warren, Ohio, has delayed the return of laid-off workers from June to August due to weak electric vehicle demand. The plant laid off 850 workers temporarily last fall and permanently cut 480 positions as EV market conditions deteriorated.
- Workers have been out since January and were initially told to expect a June return, now pushed to August based on 'detailed analysis of the electric vehicle market'
- The delay follows GM and other automakers pulling back on EV manufacturing after the loss of a $7,500 federal tax credit in late September
- Only a small number of workers have been brought back to the idled plant this month as automakers continue lowering factory output to match reduced EV demand
Replimune has reached an agreement with the FDA to resubmit its marketing application for vusolimogene oderparepvec, an experimental skin cancer drug, after two previous rejections. The company plans to resubmit in the coming days, and the FDA has indicated it will prioritize the review as an urgent matter.
- The FDA previously declined to approve the melanoma therapy twice before this agreement
- Replimune will resubmit the application for vusolimogene oderparepvec within days
- The FDA has committed to treating the resubmission as urgent and will prioritize its review upon receipt
Stellantis is recalling 419,035 vehicles in the United States due to a software error that could delay side air bag deployment during crashes, making the vehicles non-compliant with federal safety standards. The recall primarily affects 2022-2026 Jeep Grand Cherokee and 2023-2025 Jeep Grand Cherokee L models. Dealers will update the occupant restraint controller module software at no cost to owners.
- The recall covers 419,035 vehicles, including popular Jeep Grand Cherokee models from 2022-2026 and Grand Cherokee L models from 2023-2025
- A software error could delay side air bag deployment during crashes, violating U.S. Federal Motor Vehicle Safety Standards
- Stellantis will provide free software updates for the occupant restraint controller module through authorized dealers
Ocado Group announced a partnership with British supermarket chain Asda to deploy its automation technology platform across Asda's stores and dark stores beginning in 2027. This deal expands Ocado's technology licensing business in the UK grocery sector.
- Ocado will provide its automation platform to Asda stores and dark stores (fulfillment centers) starting in 2027
- The partnership represents a significant win for Ocado's technology services division in the competitive UK grocery market
- This marks another major UK supermarket adopting Ocado's warehouse automation and online grocery technology
Huawei unveiled a new chip design principle called Tau Scaling Law that focuses on boosting transmission speed through stacked circuits rather than shrinking semiconductors, offering a potential workaround to U.S. sanctions that have blocked China's access to advanced chipmaking equipment since 2019. Experts are divided on whether this represents a genuine breakthrough or an incremental improvement on existing 3D stacking technologies already used by companies like TSMC, Samsung, and SK Hynix.
- Huawei claims its new Kirin smartphone chip launching later this year will improve power efficiency by 41% and raise peak operating speed by nearly 13% compared to single-layer designs, though production yields and cost comparisons were not disclosed
- The approach requires new electronic design automation (EDA) tools and better heat management solutions, presenting significant technical barriers alongside concerns about overheating and production costs
- Nvidia CEO Jensen Huang downplayed the threat to TSMC, noting that advanced die stacking and 3D packaging technologies have been used by the industry leader for nearly a decade